Home
Contact Us Site Map Search
Reproductive Health Technologies Project  
Leadership Transition Abortion Contraception STDs Fertility News & Publications About Us
  Print this page  
 
Contraception
 
 

More than 40 years after the contraceptive revolution began with the approval of the contraceptive pill, the United States lags far behind its social and economic counterparts when it comes to effectively reducing the burdens of unintended pregnancy and of sexually transmitted infections and related fertility problems. Despite the surge of contraceptive products approved by the U.S. Food and Drug Administration (FDA) in recent years, more can and should be done to help close the gap between Americans' reproductive health needs and the information, technology and services currently available to them.

Reproductive Health Technologies Project (RHTP) monitors contraceptive technologies throughout the development pipeline – from research and development, through regulatory mechanisms, to the market, and beyond. For each specific technology, RHTP brings together a diverse group of stakeholders to define the advocacy agenda and develop and action plan. For example, sometimes we work to boost awareness and use of viable, but underutilized methods. When new scientific findings emerge that change the way the public may think about a method, RHTP takes a close look at the research, the clinical practice, and the policy to ensure that women and providers have accurate, up-to-date information.

Since its inception, RHTP has worked to ensure women have information about and access to safe, effective, and appropriate contraceptive technologies, from expanding access to emergency contraception through the Back Up Your Birth Control Campaign, to assessing the quality of information on the internet about the IUD, and reexamining the value of cervical barrier methods.

 

 
Resources
ACOG Recommends the Removal of Unnecessary Barriers to Allow Women to Access Oral Contraceptives Over-the-Counter
RHTP's press statement on the recommendations from the American College of Obstetricians and Gynecologists for making oral contraceptives available over-the-counter.
Overview of potential new male contraceptive gel
Birth Control Matters
Get involved in the campaign to make birth control available with no copays. 

Contraceptive Methods in the Pipeline
These tables, updated in December 2008, contain R&D information about an array of emerging contraceptives.

Emerging Female    Contraception [PDF, 63KB]

Emerging Male        Contraception [PDF, 95KB]

Emerging Postcoital Contraception [PDF, 53KB]

December 2008 FDA Final Rule on Male Latex Condom Labeling: Memo to Interested Parties

Summary of New Contraceptive Technologies
A short update of new contraceptive methods from the National Partnership for Women and Families' Monthly Women's Health Research Review.
RHTP Comments to FDA Reproductive Health Drugs Advisory Committee
[PDF, 491KB]
Unfinished Revolution in Contraception: Convenience, Consumer Access and Choice
A report from an October 2003 meeting. [PDF, 93KB]

Contraception in the United States: Current Use and Continuing Challenges
This presentation from The Alan Guttmacher Institute (AGI) brings together the most current information available on contraceptive use, development and barriers to access in the U.S. [PowerPoint, 938KB]

 
 
Abortion | Contraception | STDs | Fertility | News & Publications | About Us
Contact Us | Site Map